GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

Regulation of cyclosome/APC in the human cell cycle

$81,000
Technion-Israel Institute Of Technology · R01 · FY2003 · GM

Cancer Immunology and Immunotherapy Program

$80,975
Larry R Pease · Mayo Clinic Rochester · P30 · FY2019 · CA

Advancing the translatability of mouse models for cancer immunotherapy

$80,750
Rosemary J Akhurst · University Of California, San Francisco · R01 · FY2021 · CA

Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma

$80,426
Defne Bayik Watson · University Of Miami School Of Medicine · R00 · FY2023 · CA

A physical sciences approach to investigate the role of exosomes in metastatic progression

$80,309
Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2023 · CA

Immune Checkpoint Regulation by the Integrated Stress Response Pathway in Lung Ca

$80,224
Shayna Thomas-Jardin · Ut Southwestern Medical Center · F32 · FY2025 · CA

Transposon control as a checkpoint during regeneration

$80,224
Krista Marie Angileri · Cornell University · F32 · FY2025 · EY

In vivo imaging of mitochondria structure and function in therapy resistant lung tumors

$80,098
David B Shackelford · University Of California Los Angeles · R01 · FY2024 · CA

P3 - Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer

$80,098
Theodore S Lawrence · University Of Michigan At Ann Arbor · P50 · FY2014 · CA

Kinetochore Structure and Function

$80,034
Timothy Yen · Research Inst Of Fox Chase Can Ctr · R01 · FY2010 · GM

IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level

$80,000
Agne Petrosiute · Case Western Reserve University · R03 · FY2018 · CA

Study of the check point inhibitors with or without antifungals on the natural history of murine invasive pulmonary aspergillosis

$80,000
Dimitrios P Kontoyiannis · University Of Tx Md Anderson Can Ctr · R03 · FY2018 · AI

IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level

$80,000
Agne Petrosiute · Case Western Reserve University · R03 · FY2017 · CA

Study of the check point inhibitors with or without antifungals on the natural history of murine invasive pulmonary aspergillosis

$80,000
Dimitrios P Kontoyiannis · University Of Tx Md Anderson Can Ctr · R03 · FY2019 · AI

Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences

$79,817
Dennis E. Discher · University Of Pennsylvania · U01 · FY2023 · CA

Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD

$79,631
Richard M Longnecker · Northwestern University At Chicago · R01 · FY2011 · CA

Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD

$79,381
Richard M Longnecker · Northwestern University At Chicago · R01 · FY2012 · CA

Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling

$79,379
Ankur Singh · Cornell University · R01 · FY2020 · AI

Targeting Wnt signaling in therapy-resistant ovarian cancer

$79,331
Benjamin G Bitler · University Of Colorado Denver · R37 · FY2024 · CA

Development of Molecular Microbubble Probes and Ultrasound-Guidance in Immunotherapeutic Strategies

$79,298
Ahmed El Kaffas · Stanford University · R21 · FY2022 · EB

Experimental Therapeutics Program

$79,273
Hans Hammers · Ut Southwestern Medical Center · P30 · FY2021 · CA

Experimental Therapeutics Program

$79,273
Hans Hammers · Ut Southwestern Medical Center · P30 · FY2023 · CA

Experimental Therapeutics Program

$79,273
Hans Hammers · Ut Southwestern Medical Center · P30 · FY2024 · CA

Experimental Therapeutics Program

$79,273
Hans Hammers · Ut Southwestern Medical Center · P30 · FY2022 · CA

Acoustic assembly of patient tumor organoids for modeling cancer immunity

$79,250
Feng Guo · Trustees Of Indiana University · R03 · FY2020 · EB